Cinryze C-1
Ended Awarded Last action
- Contract number
- 36C26124N0169
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $129,842
Award facts
- Contract value 100% obligated
- $129,841.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$40,442 | |
| Original award | $170,284 |
About this award
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, a leading global biopharmaceutical company. The delivery order, valued at $129,841.55, is for the provision of CINRYZE C-1, a specialty pharmaceutical product, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. Takeda Pharmaceuticals America Inc. has an established history of supplying critical medications, including treatments for hemophilia, immune deficiencies, hereditary angioedema, and other rare diseases, to federal agencies such as the VA, Department of Justice's Bureau of Prisons, and Department of Defense. This delivery order is part of a Blanket Purchase Agreement (BPA) valued at over $19 million that Takeda has in place with the VA National Acquisition Center, which aims to streamline the procurement of these specialized pharmaceutical therapies for eligible VA patients. There is no set-aside designation for this contract.
Quick answers
Who was awarded contract 36C26124N0169?
36C26124N0169 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C26124N0169 worth?
The government has obligated $129,842 on 36C26124N0169.
Is contract 36C26124N0169 an order under another contract?
Yes. 36C26124N0169 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0169 competed?
The extent of competition for 36C26124N0169 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award